Search - tctmd.com

Displaying 181 - 200 of 1134

Sort: Relevancy | Date

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Features

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Michael O'Riordan

February 19, 2025

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Shelley Wood

November 16, 2024

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Presenter: Jung-Min Ahn

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Akiko Maehara

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Vinayak Bapat

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Neil Fam

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Mamas Mamas

October 30, 2024

Presentation TCT 2024

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Presenter: Birgitte Krogsgaard Andersen

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Case Based Example 2

Presenter: Margaret McEntegart

October 30, 2024

Presentation TCT 2024

A Primer on DCB Technology and Requirements for Success

Presenter: Juan Granada

October 30, 2024

Presentation TCT 2024

Case Based Example 1

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Top Five Insights from the ARC-DCB Consortium

Presenter: Simone Fezzi

October 30, 2024

Presentation TCT 2024

How I Use DCBs: A Lens Into the Future

Presenter: Antonio Colombo

October 30, 2024

Advertisement

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Editorial Comments

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Editorial Comments

Editorial Comments

Editorial Comments

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Case Based Example 2

A Primer on DCB Technology and Requirements for Success

Case Based Example 1

Top Five Insights from the ARC-DCB Consortium

How I Use DCBs: A Lens Into the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content